Song Zhang is currently a Ph.D. student at Kangwon National University, Korea. He is actively working on phage therapy. Recently, he was also involved in the discovery of efflux pump inhibitors and beta-lactamase inhibitors. He published an article entitled Advances in the discovery of efflux pump inhibitors as novel potentiators to control antimicrobial-resistant pathogens.